Others surely felt that DSL and its technology were a waste, but I never did, nor have I ever heard a cogentargument that suggests this area will not remain a dominant form of broadband for decades to come.
Yet, without a cogent economic argument for payors (and, increasingly, for regulators), drug developers are going to have an increasingly difficult time getting their products into the hands of their primary customers.